Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Thyroid disease in pregnancy

Obstetrics and gynaecology · UK scope · Sources checked 7 Sept 2026 · Clinical review pending

RapidFull
!
Thyroid storm or antithyroid toxicity needs urgent care

Marked tachycardia with fever, agitation, heart failure or altered consciousness can indicate thyroid storm; fever or sore throat during thionamide treatment can signal agranulocytosis.

Action: Arrange emergency medical and obstetric assessment for systemic decompensation. With suspected antithyroid-drug agranulocytosis, withhold further doses pending urgent full blood count and specialist advice; jaundice or hepatic pain requires urgent liver assessment.

Synopsis

Interpret thyroid tests using pregnancy-specific physiology, treat maternal hormone deficiency or excess safely, and recognise antibody-mediated fetal risk and antithyroid-drug emergencies.

  • Interpret TSH and free T4 with trimester-specific and assay-specific reference ranges; normal early-pregnancy physiology may suppress TSH.
  • Established hypothyroidism needs prompt levothyroxine adjustment at a positive pregnancy test, often two extra usual daily doses per week under the pre-agreed plan.
  • RCOG recommends TSH and free T4 every four to six weeks until 20 weeks, then again at 28 weeks for levothyroxine-treated hypothyroidism.
  • For treated hypothyroidism aim for TSH below 2.5 mU/L while keeping free T4 within the appropriate pregnancy reference range.
  • If antithyroid treatment is necessary in early pregnancy, RCOG favours propylthiouracil; a carbimazole-to-PTU switch should occur promptly before 10 weeks when indicated.
  • Use the lowest effective antithyroid dose, targeting free T4 in the upper half of the pregnancy range rather than normalising TSH aggressively.
  • Gestational transient thyrotoxicosis generally needs supportive care, and euthyroid thyroid-peroxidase-antibody positivity alone does not justify levothyroxine.
  • Past Graves' disease still warrants TRAb assessment because antibodies can affect the fetus even after thyroidectomy or radioiodine.

Key red flags

Fever, confusion, severe tachycardia or pulmonary oedema in a thyrotoxic patient requires emergency treatment for possible thyroid storm.

Sore throat, mouth ulcers, fever or unexplained infection while taking carbimazole or propylthiouracil requires immediate blood-count assessment and withholding the medicine until reviewed.

Jaundice, dark urine, pruritus or right upper quadrant pain while taking propylthiouracil raises concern for severe hepatotoxicity.

Investigation priorities

01
TSH and free T4First step

Classify dysfunction and guide treatment using gestation-appropriate interpretation.

Management branches

Replacement adjustmentMeet the increased thyroxine requirement

Pregnancy is confirmed in someone with established levothyroxine-treated hypothyroidism.

  1. Activate the agreed empirical dose increase and arrange prompt TSH and free T4 testing rather than waiting for routine antenatal booking.
  2. Titrate to the RCOG pregnancy target and check every four to six weeks until 20 weeks, then at 28 weeks.
  3. Review iron and calcium timing, vomiting and missed doses, and document the postnatal dose and testing plan.

Key medicines

Levothyroxine in established hypothyroidismAt a positive pregnancy test, take the usual oral daily dose on five days weekly and twice that dose on two days weekly when following the agreed RCOG plan; subsequently individualise against TSH and free T4.This schedule modifies an existing dose; newly diagnosed disease needs an individual starting prescription. Separate iron or calcium from levothyroxine and avoid biochemical overtreatment.
PropylthiouracilUse an endocrinologist-selected oral dose and titrate to maternal free T4 with the lowest effective exposure. The cited SmPC gives a general adult initiation range of 300–600 mg daily, once daily or divided; this is not a recommended pregnancy starting range, and pregnancy treatment may require substantially less.Do not automatically use the top of the general adult range. Watch for agranulocytosis, hepatotoxicity and fetal hypothyroidism, and consider carbimazole if ongoing treatment is needed beyond 20 weeks.
Open full textbook →Answer 2 questions
Sources and review status6 sources · checked 7 Sept 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

  • RCOG Green-top 76: Management of thyroid disorders in pregnancy
  • RCOG Green-top 76: May 2026 correction
  • RCOG: Thyroid problems in pregnancy
  • NHS: Levothyroxine medicine information
  • MHRA: Carbimazole congenital-malformation risk
  • Propylthiouracil 50 mg: February 2026 SmPC

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom